Vivos (RDGL) Operating Income Growth (3y) (2013 - 2025)
Powered by 
Analysis
Vivos (RDGL) Operating Income Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.06% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -15.80% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | 5.02% |
| Mar 31, 2025 | -4.93% |
| Dec 31, 2024 | -44.70% |
| Sep 30, 2024 | -63.03% |
| Jun 30, 2024 | 34.44% |
| Mar 31, 2024 | -34.90% |
| Dec 31, 2023 | -47.26% |
| Sep 30, 2023 | -74.94% |
| Jun 30, 2023 | -92.37% |
| Mar 31, 2023 | -27.30% |
| Dec 31, 2022 | -29.55% |
| Sep 30, 2022 | 23.01% |
| Jun 30, 2022 | -65.73% |
| Mar 31, 2022 | -49.17% |
| Dec 31, 2021 | 49.77% |
| Sep 30, 2021 | -12.43% |
| Jun 30, 2021 | -75.68% |
| Mar 31, 2021 | 6.40% |